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Abstract
Background: Autonomic dysregulation has been recently reported as a feature of autism spectrum disorder (ASD).
However, the nature of autonomic atypicalities in ASD remain largely unknown. The goal of this study was to
characterize the cardiac autonomic profile of children with ASD across four domains affected in ASD (anxiety,
attention, response inhibition, and social cognition), and suggested to be affected by autonomic dysregulation.
Methods: We compared measures of autonomic cardiac regulation in typically developing children (n = 34) and
those with ASD (n = 40) as the children performed tasks eliciting anxiety, attention, response inhibition, and social
cognition. Heart rate was used to quantify overall autonomic arousal, and respiratory sinus arrhythmia (RSA) was
used as an index of vagal influences. Associations between atypical autonomic findings and intellectual functioning
(Weschler scale), ASD symptomatology (Social Communication Questionnaire score), and co-morbid anxiety
(Revised Children’s Anxiety and Depression Scale) were also investigated.
Results: The ASD group had marginally elevated basal heart rate, and showed decreased heart rate reactivity to
social anxiety and increased RSA reactivity to the social cognition task. In this group, heart rate reactivity to the social
anxiety task was positively correlated with IQ and task performance, and negatively correlated with generalized
anxiety. RSA reactivity in the social cognition task was positively correlated with IQ.
Conclusions: Our data suggest overall autonomic hyperarousal in ASD and selective atypical reactivity to social
tasks.
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Background
Autism spectrum disorder(ASD) is a complex neurode-
velopmental disorder defined by qualitative impairments
in social communication, and by the presence of repeti-
tive behaviors and restrictive interests. An extensive body
of literature suggests that ASD symptoms are associated
with pervasive atypicalities in the central nervous sys-
tem [1], including structures and networks involved in the
regulation of the autonomic nervous system (ANS). For
example, ASD has been associated with atypicalities in the
amygdala [2-5], the anterior cingulate cortex [6], and the
insula [7,8] - structures that play a key role in modula-
tion of the ANS response. It is therefore not surprising
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that, recently, a number of studies have reported atyp-
icalities at the level of the peripheral nervous system,
specifically pertaining to the dysregulation of the ANS [9].
These include reports of elevated basal heart rate [10-13],
decreased baseline vagal tone [11-14], and blunted heart
rate response to psychosocial challenges [15-17]. ANS
indices have also been associated with core and co-morbid
symptomatology in ASD. For example, decreased basal
respiratory sinus arrhythmia (RSA) has been associated
with difficulties in social behavior [14,18], decreased lan-
guage abilities [18,19], internalizing symptoms [14], and
cognitive delay [19].
Despite this early evidence of ANS dysregulation in
ASD, wide variability in samples, methods, and mea-
sures has produced inconsistent literature findings [20].
As previously mentioned, the ANS has direct and indi-
rect connections to a number of cortical and subcortical
brain regions whose structure, function, and connectivity
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are affected in ASD (for example, prefrontal, limbic, and
frontal networks, the hypothalamus, and the brainstem).
Moreover, ANS function is closely linked to behavior,
cognition, and emotion processing [20], and indices of
its function have been associated with differences in
domains affected in ASD [21] such as social behavior [22],
emotion regulation [23], attention [24], response inhibi-
tion [25], and adaptive functioning [26]). Given the close
association between the ANS and both the central ner-
vous system and behavioral domains, ANS atypicalities,
if found, can ultimately serve as non-invasive and inex-
pensive markers for deficits and co-morbidities associated
with ASD. The objective of this study was to address the
paucity of literature in understanding ANS dysregulation
in ASD by characterizing the autonomic profile of chil-
dren with ASD across four domains associated with ASD
and affected by ANS dysregulation (anxiety, attention,
response inhibition, and social cognition). We hypothe-
sized that individuals with ASD would show hyperarousal
of the ANS. This is supported by the high prevalence of
co-morbid anxiety in ASD [27], the genetic, neurobiologi-
cal, and pheonotypical overlap between the two disorders
[28-31], and the findings of physiological hyperarousal
in anxiety disorders [32-34]. We also expected atypi-
cal ANS reactivity to attention, response inhibition, and
social cognition tasks in ASD based on previous reports




We recruited a sample of typically developing (TD) chil-
dren (n = 36) and children with ASD (n = 47) for the
study (Figure 1). The inclusion criteria for the TD group
were 8 to 18 years of age, no diagnosis of ASD or any
other developmental, neurological, or psychiatric disor-
ders, medication-free at the time of the study, and no
premature birth (born after 35 weeks gestational age). The
inclusion criteria for the ASD groupwere age 8 to 18 years,
primary diagnosis of ASD, and ability to perform the study
tasks. Children in the ASD group were diagnosed by an
expert, research reliable team using the DSM-IV criteria
supported by the Autism Diagnostic Observation Sched-
ule (ADOS) [38] and the Autism Diagnostic Interview -
Revised (ADI-R) [39].
The Bloorview Research Institute research ethics board
approved the study. Participants deemed to have capacity
for consent, provided written consent. For all other par-
ticipants, assent and written consent were obtained from
the children and their legal guardians, respectively.
Procedures
After consent, participants completed a 2-hour study in
one session. During the session, they sat in front of a
Figure 1 Participant numbers at different stages of the study.
computer screen and completed five tasks, each preceded
and followed by a baseline task. The tasks were:
• Color Stroop (Color-Word Interference) test [40].
This task was used to elicit an ANS stress reaction
[41,42], and shown to elicit both psychological and
physiological arousal responses in typically
developing populations [43] as well as children with
ASD [10]. Participants completed a computerized,
single-trial version of the task which involved the
presentation of words corresponding to color names,
printed in differently colored letters. The participants
were required to name the color of the letters while
ignoring the printed word. The task consisted of 5,
one-minute blocks in which stimulus presentation
frequency varied from 2 to 1.25 seconds/word (blocks
one and five: 2 seconds/word, blocks 2 and 4: 1.5
seconds/word, block 5: 1.25 seconds/word). During
the first and last blocks, only congruent stimuli were
presented, whereas the remaining blocks consisted of
only incongruent stimuli. Prior to starting the task,
participants were provided with ten practice stimuli
to ensure understanding of the task. Performance on
Kushki et al. Molecular Autism 2014, 5:39 Page 3 of 10
http://www.molecularautism.com/content/5/1/39
this task was measured as the percentage of correct
responses.
• Public speaking. For this task, participants were
given 2 minutes to prepare a 3-minute talk on a
topic of their choice. The talk was then delivered to
three strangers. Public speaking tasks have been
successfully used in previous studies examining
cardiac responses to anxiogenic stimuli in
neurotypical individuals [44-46] and in children
with ASD [15,47]. Performance on this task was
measured as the percentage of the time that the
participant did not speak or vocalize during the
task.
• Rapid visual information processing (CANTAB,
http://www.camcog.com/). In this test of sustained
attention and working memory [48], participants
were presented with random single-digit numbers
(2 through 9) at a rate of 100 digits per minute and
asked to identify a prespecified three-digit sequence
(for example, 3-5-7) by pressing the space bar. The
duration of this task was 4 minutes. Performance was
measured as the percentage of correctly identified
sequences.
• Stop signal task [49]. This was a test of response
inhibition. Participants were presented with a series
of X’s and O’s and asked to press the left and right
buttons on a gamepad when X’s and O’s appeared,
respectively. The stimuli were occasionally followed
by an auditory tone (stop signal), requiring the
participants to withhold their response. The task
consisted of 5 blocks, with 24 trials per block. The
first block was practice. Total length of task was
approximately 10 minutes. Task performance was
measured as the latency of the stop process (stop
signal reaction time (SSRT)) in milliseconds [50].
• Reading the Mind in the Eyes - child version [51].
This was a test of social cognition (theory of mind)
where participants were presented with a set of 28
photographs depicting the eye region of the face,
and asked to choose the word that best described
what the person was thinking or feeling from a set
of four choices. Performance was measured as the
number of correct responses.
For the baseline task, participants watched clips of
animated movies. All baseline tasks were 5 minutes in
duration, except for the initial baseline which was 15 min-
utes long to allow acclimation to the environment and
sensors.
Measures
ASD symptom severity was further characterized using
the Social Communication Questionnaire (SCQ). The
parent version of the Revised Child Anxiety and
Depression Scale (RCADS-P) [52] was used to charac-
terize anxiety symptomatology in this group along scales
corresponding to five DSM-IV anxiety disorders (sepa-
ration anxiety disorder, social phobia, generalized anx-
iety disorder, obsessive-compulsive disorder, and panic
disorder). Given the nature of our tasks, only scales cor-
responding to generalized anxiety disorder and social
phobia were considered in the analyses. Intellectual func-
tioning was assessed in both groups using the Wechsler
Scales of Intelligence (Wechsler Abbreviated Scale of
Intelligence (I and II), and the Wechsler Intelligence Scale
for Children IV). For one participant in the TD group, an
existing intelligence score (the Stanford-Binet Intelligence
Scale) was used.
A three-lead electrocardiogram (ECG) was measured
using a wearable sensor from Shimmer Research. The
ECG time series, sampled at 256 Hz, was transmitted over
BlueTooth to a laptop computer and stored. Analyses were
carried out offline using Matlab. Heart rate (HR) was cal-
culated as the inverse of inter-beat (RR) intervals extracted
using a modified version of the algorithms presented in
the works [53,54]. In particular, the ECG signal was band-
pass filtered between 5 and 15 Hz to maximize the QRS
energy and to remove artifact noise, including baseline
wandering, motion artifacts, and electrical noise. The sig-
nal was then differentiated, squared, and integrated using
a 200-ms window. Peaks of the integrated signals were
detected as R-waves using a detection threshold of 0.15
times the median of the past ten beats and a blank-
ing period of 200 ms. The RR sequence then underwent
an outlier filtering algorithm which removed RR values
outside of acceptable limits. High and low limits were
computed as 75% and 150% of the average of the median
of all beats and the median of eight preceding beats. This
combination was used to allow for adaptation to changes
in median RR-interval over time. The ensuing analyses
used RR values from the last 3 minutes of each task
interval.
To compute RSA, each RR sequence was uniformly sam-
pled at 8 Hz using cubic interpolation and filtered using
a third-order, 21-point polynomial filter to remove the
variance associated with activities at frequencies lower
than spontaneous breathing [55,56]. The filtered signal
was then subtracted from the original resampled sequence
and the power spectral density of this residual sequence
was estimated using Welch’s averaged modified peri-
odogram method (Hamming window, 800-point Fourier
transform).
RSA was calculated as the natural logarithm of the total
power (that is, the summation of the spectral compo-
nents) in the frequency band 0.24 to 1.04 Hz, which is
used in studies of vagal functioning in children [57]. The
analyses were repeated using the frequency band 0.15 to
0.40 Hz [58], but the conclusions remained unchanged.
Kushki et al. Molecular Autism 2014, 5:39 Page 4 of 10
http://www.molecularautism.com/content/5/1/39
Statistical analyses
Statistical analyses were performed using SAS version 9.4
(SAS Institute, Cary, NC). To investigate group differences
in HR and RSA, repeated measures multiple regression
analysis was used to examine the significance of group ×
task interaction using individual models for eachmeasure.
Sex, IQ, and age were included as covariates in these mod-
els. For RSA, mean baseline HR was also included as a
covariate [59]. Using these models, we examined group
differences in baseline HR and RSA, as well as reactivity
in these measures in response to each task using contrast
statements. In post hoc analyses, stepwise regression was
used to examine whether baseline and reactivity cardiac
measures were significantly predicted by demographic
variables (age, full-scale IQ, sex), autism symptomatol-
ogy (SCQ), trait anxiety (RCADS scores on the general-
ized anxiety disorder and social phobia subscales), and
task performance. Stepwise regression combined forward
selection and backward elimination with alpha-to-enter
and alpha-to-remove set to 0.1.
We tested for group differences on task performance
using generalized linear models, which can be used for
non-normally distributed errors, adjusting for age, sex,
and full-scale IQ. Outcomes were modeled for the normal,
Poisson, zero-inflated Poisson, and zero-inflated negative
binomial distribution as appropriate.
For all analyses, if a participant did not complete a task,
the data from that task were treated as missing but the
data from remaining tasks were used in the analysis.
Results
Participants
Due to technical difficulties with the data collection soft-
ware, two participants in the TD group and three partici-
pants in the ASD group were excluded from the analyses.
Three participants with ASD refused to comply with study
protocol and were excluded. Data from an additional par-
ticipant in the ASD group were excluded because of a fire
alarm during the session. The demographic information
for the remaining participants is shown in Table 1, and
participant numbers during different stages of the study
are shown in Figure 1.
Of the 40 children in the ASD group, 8 were takingmed-
ications at the time of the study. These included serotonin
norepinephrine reuptake inhibitors (SNRIs) (Strattera),
selective serotonin reuptake inhibitors (SSRIs) (Prozac,
Zoloft, citalopram), stimulants (Ritalin, Biphentin, Con-
certa), and atypical antipsychotics (risperidone, Abil-
ify). Co-morbid conditions reported by participants in
the ASD group included attention deficit hyperactiv-
ity disorder (ADHD) symptoms (6), anxiety symptoms
(4), developmental coordination disorder (2), history of
hydrocephalus (1), dyslexia (1), and learning disability (1).
One participant in the ASD group was born at 34 weeks.
Table 1 Participant characteristics
TD (n= 34) ASD (n= 40) P value
(group effect)
Age 12.5 ± 2.9 12.0 ± 2.9 0.5
Full-scale IQ 113.1 ± 13.9 92.9 ± 20.6 < 0.0001
Sex (male:female)∗ 19:15 33:7 0.02
SCQ 18.0 ± 8.1
RCADS-SAD 61.9 ± 17.4
RCADS-GAD 58.6 ± 16.3
RCADS-PD 57.3 ± 17.5
RCADS-SP 53.1 ± 11.3
RCADS-OCD 54.1 ± 10.5
RCADS-total anxiety 58.4 ± 14.8
*Fisher’s exact test.
RCADS: Revised Child Anxiety and Depression Scale; SCQ: Social Communication
Questionnaire; SAD: separation anxiety disorder; GAD: generalized anxiety
disorder; PD: panic disorder; SP: social phobia; OCD: obsessive-compulsive
disorder.
The RR outlier filtering algorithm retained an average of
98.6%± 2.2% of participant data.More than 5% of the data
were removed for one participant in the TD group (10%
removed) and two participants in the ASD group (9% and
13%). Exclusion of these participants did not change any
of the conclusions reported in the following sections.
Task performance
Table 2 reports the performance results for both the TD
and ASD groups. After controlling for age, sex, and full-
scale IQ, the performance of children in the ASD group
was not significantly different than that of the TD group
on any of the five tasks in this study (Table 3).
HR
The mean HR for each task is shown in Figure 2 for
the TD and ASD groups. For HR, repeated measures
analysis revealed a significant group × task interaction
(F(10,711) = 4.79, P < 0.0001). The ASD group had sig-
nificantly higher baseline (movie 1) HR (estimated group
difference = 6.02 ± 3.03 beats/minute, t(711) = −1.99,
P = 0.047). The ASD group also had significantly
Table 2 Task performance for the typically developing
(TD) and autism spectrum disorder (ASD) groups
(mean± standard deviation)
TD ASD
Stroop task (% correct) 85.5 ± 17.9 67.6 ± 30.8
Public speaking (seconds silence) 37.6 ± 40.6 65.2 ± 51.3
RVP (% correct) 91.8 ± 11.2 81.2 ± 19.4
Stop task (SSRT (ms)) 325.0 ± 110 214.5 ± 86
Reading the Mind in the Eyes (# correct) 23.4 ± 3.1 20.1 ± 4.6
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Table 3 Comparison of performance between groups after
controlling for IQ, age, sex (mean± standard error)
TD ASD P value
(group effect)
Stroop task (% correct) 85.3 ±2.1 80.8 ± 2.6 0.18
Public speaking 3.2 ± 0.2 3.6 ± 0.2 0.21
(log(seconds silence))
RVP (% correct) 85.1 ± 2.4 84.5 ± 2.5 0.87
Stop task (SSRT (ms)) 339.0 ± 18.1 306.8 ± 19.0 0.25
Reading the Mind 18.8 ± 0.5 18.6 ±0.5 0.73
in the Eyes (# correct)
decreased HR reactivity during the public speaking task
(estimated group difference (speaking - pre baseline) =
6.28 ± 1.31 beats/minute, t(711) = 4.79, P < 0.0001; esti-
mated group difference (speaking - post baseline)= 6.38±
1.31 beats/minute, t(711) = 4.87, P < 0.0001). Exclusion
of the ASD participants on medications increased the P
value for the baseline group difference (estimated group
difference = −5.88 ± 3.19 beats/minute, t(632) = −1.85,
P = 0.066). No significant group differences were found
for HR reactivity in the Stroop, rapid visual information
processing, stop signal, or Reading the Mind in the Eyes
tasks.
RSA
The mean RSA for each task is shown in Figure 3 for
the TD and ASD groups. Repeated measures analysis did
not show a significant group × task interaction on RSA,
and there was no significant difference in baseline RSA
between the groups. However, in response to the Read-
ing the Mind in the Eyes task, there was a marginally
larger decrease in RSA in the ASD group (estimated group
difference (Eyes - pre baseline) = 0.21 ± 0.11 log(ms2),
t(708) = 1.8, P = 0.07) and a larger RSA increase during
recovery from the Reading the Mind in the Eyes task (esti-
mated group difference (Eyes - post baseline)= 0.24±0.12
beats/minute, t(708) = 1.9, P = 0.06). Exclusion of the
medication group decreased the P value (estimated group
difference (Eyes - pre- baseline) = 0.22 ± 0.12 log(ms2),
t(629) = 2.15, P = 0.03; estimated group difference (Eyes -
post baseline) = 0.25 ± 0.13 beats/minute, t(629) = 1.88,
P= 0.06). This also revealed amarginally significant group
difference in recovery from the stop signal task (estimated
group difference (stop task - post baseline) = 0.25 ± 0.13
log(ms2), t(629) = 1.94, P = 0.05), and in change and
recovery from the RVP task (estimated group difference=
0.2 ± 0.11 log(ms2), t(629) = 1.74, P = 0.08). No signif-
icant group differences were found for RSA reactivity in
the Stroop, public speaking, or rapid visual information
processing tasks.
Association with demographic, anxiety, and performance
measures
Table 4 summarizes the results of the post hoc correlation
analysis examining associations between HR and RSA,
and demographic, anxiety, and performance measures in
the ASD group. The analyses were conducted for mea-
sures/task pairs for which significant group differences
were revealed by the repeated measures analyses in the
previous sections. After removing the medication group,
stepwise regression revealed that the only significant
Figure 2 HR: Mean across tasks for the TD and ASD groups. Error bars represent standard error.
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Figure 3 RSA: Mean across tasks for the TD and ASD groups. Error bars represent standard error.
predictor of baseline HR was age (model R-square =
0.14). HR change (speaking - pre baseline) was pre-
dicted by full-scale IQ and RCADS generalized anxiety
score (model R-square= 0.36; partial R-squares: full-scale
IQ = 0.20, generalized anxiety = 0.17). HR recovery
during public speaking (speaking - post baseline) was pre-
dicted by full-scale IQ, RCADS generalized anxiety score,
and performance on the task (model R-square= 0.46; par-
tial R-squares: full-scale IQ = 0.15, generalized anxiety =
0.18, performance = 0.12).
The only significant predictor of RSA change during
the Reading the Mind in the Eyes task was full-scale IQ
(Eyes - pre baseline model R-square = 0.29; Eyes - post
baseline model R-square = 0.20).
Discussion
Our results suggest atypical cardiac findings in the ASD
group despite group differences on task performance.
These findings include cardiac hyperarousal in the ASD
group as well as atypical responses to the public speak-
ing and Reading the Mind in the Eyes tasks. In particular,
while not statistically significant, we found that the ASD
group had an elevated heart rate during the experimental
session. Moreover, this group showed a blunted heart rate
response to public speaking which was correlated with
full-scale IQ and generalized anxiety score, and an exag-
gerated RSA response to the Reading theMind in the Eyes
task which was correlated with full-scale IQ.
Our data also showed that medication effects accounted
for a marginal difference in the outcomes. This suggests
that future studies on ANS functioning should report on
the use of medications in their samples and account for
their potential effects on ANS measures.
Task performance
We did not find any group differences in task perfor-
mance after adjusting for age, sex, and full-scale IQ. In the
absence of such differences, ANS atypicalities may suggest
compensatory mechanisms applied by the ASD group.
Reflecting the heterogeneity in the autism spectrum,
there is considerable variability in the literature regarding
performance on the tasks used in this study. For example,
Table 4 Associations between cardiac variables and demographic, anxiety, and performancemeasures for the ASD group
Age IQ RCADS GAD Performance
Baseline HR -1.57 ± 0.70∗
HR speaking-pre baseline 0.18 ± 0.05∗∗ -0.15 ± 0.06∗
HR speaking-post baseline 0.19 ± 0.06∗∗ -0.18 ± 0.06∗ 0.08 ± 0.04∗
RSA Eyes-pre baseline -0.02 ± 0.005∗∗
RSA Eyes-post baseline -0.01 ± 0.005∗
Only significant regression slopes (β) are reported. ∗P < 0.05, ∗∗P < 0.005. HR: heart rate; RSA: respiratory sinus arrhythmia; speaking: public speaking task; Eyes:
Reading the Mind in the Eyes task; RCADS: Revised Child Anxiety and Depression Scale; GAD: generalized anxiety disorder.
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regarding the Stroop and stop signal tasks, several studies
have reported no performance differences whereas oth-
ers have reported significant group effects (see [60] for
a review). With regard to public speaking, no group dif-
ferences were found in the length of the public speech
between ASD and TD participants (although physiologi-
cal differences were found) [15]. With regard to the Read-
ing the Mind in the Eyes Task, our results are adjusted for
IQ, age, and sex. Our unadjusted means for the TD and
ASD groups are well in line with the literature which has
reported significant group differences [61]. Our analysis
of task performance differences may be limited by the fact
that the ASD and TD were not matched on IQ, as this
may have reduced the statistical power to detect signifi-
cant group differences. Future studies with larger sample
sizes are needed to further investigate these differences.
Baseline differences
Previous literature on cardiac measures of ANS have
reported either hyperarousal [10-13,62] or no baseline
atypicalities in ASD [47]. Consistent with the hyper-
arousal hypothesis, our data indicate that children with
ASD had marginally significantly elevated HR at base-
line compared to the typically developing children. These
results replicate our own findings of basal hyperarousal in
[10]. This hyperarousal trend persisted through the four
domains examined in this study, although the difference
did not reach statistical significance. This hyperarousal
may be associated with co-morbid anxiety in ASD, a fea-
ture of ASD itself, or a manifestation of the interaction of
ASD and anxiety symptoms.
• Co-morbid anxiety in ASD: Anxiety disorders are
one of the most prevalent co-morbidities in ASD [27]
and may exacerbate or occasionally drive the core
deficits of ASD [30]. While the nature of anxiety in
ASD is still largely unknown [63], ASD has been
associated with genetic [28,29], neurobiological, and
phenotypical overlap with anxiety disorders [30,31].
From a neurobiological perspective, both ASD and
anxiety disorders have been associated with
differences in central structures involved in
emotional processing (such as the amygdala, anterior
cingulate cortex, prefrontal cortex, and the insular
cortex) [64,65]. In terms of phenotypic presentation,
ASD and anxiety are thought to present with
overlapping symptoms related to repetitive and
restrictive interests (for example, perseverative
behavior), social and emotional reciprocity,
avoidance behaviors, and speech difficulties
[31,63,66]. Interestingly, subclinical ASD traits have
been reported in children with anxiety disorders [31].
The clinical presentation of anxiety is conceptualized
as having three interconnected dimensions:
behavioral (such as crying, avoidance, or tantrums),
subjective-cognitive (such as maladaptive or negative
thoughts), and physiological (such as increased heart
rate or perspiration) [67,68]. The latter often
manifests itself as a “fight or flight” response which is
associated with excitation and inhibition of the
sympathetic and parasympathetic branches of the
ANS, respectively. Highlighting the role of the
physiological dimension, chronically elevated HR has
been reported in anxiety disorders [32-34]. A similar
pattern was found in the present study, suggesting
physiological symptom overlap between ASD and
anxiety disorders. As such, the hyperarousal found
herein may reflect the cardiac signs of co-morbid
anxiety.
In this study, we did not find a significant correlation
between baseline HR and trait anxiety measured by
the RCADS. Previous literature findings on this
association are mixed [45].
• Hyperarousal as a feature of ASD: ANS
hyperarousal may also be related to neurobiological
differences associated with ASD. Although the ANS
response is modulated both at the central and
peripheral levels, in the absence of any evidence
indicating primary ANS dysfunction in ASD, we
suggest that hyperarousal of the ANS system may
be secondary to hyperarousal at the central level.
At this level, hyperarousal may be associated with
over-responsivity of networks involved in
perception, processing, and responding to emotional
stimuli [34]. Processes that may contribute to this
over-responsivity include increased threat
perception, increased and misinterpreted perception
of bodily sensations [34], or decreased inhibition of
the fear response. ASD has been associated with
neurobiological differences in brain networks
responsible for these functions (for example, the
prefrontal cortex, the insular cortex, and the anterior
cingulate cortices) [6], and aspects of these
differences have been associated with anxiety
symptom severity [69,70]. For example, total and
right amygdala volumes have been positively
associated with scores on the anxiety subscale of the
Child Behavior Checklist [69] in a sample of children
with ASD. At the same time, ASD has been associated
with enlargement of the amygdala [2-4]. While these
findings further support the role of the central
nervous system in ANS hyperarousal, neuroimaging
studies are needed to examine this hypothesis.
• Interaction of ASD and anxiety features: The
observed hyperarousal in our sample may also be
related to an interaction between anxiety and ASD
features. For example, ASD features such as sensory
sensitivities, insistence on sameness, or other
Kushki et al. Molecular Autism 2014, 5:39 Page 8 of 10
http://www.molecularautism.com/content/5/1/39
affective and cognitive deficits may lead to increased
stressors experienced by this population, which can
ultimately lead to increased arousal [63,71].
Moreover, neurological dyregulation (for example, in
threat perception or in introception) may further
increase the susceptibility to conditioning by negative
experiences and hyperarousal.
We did not find evidence of reduced parasympathetic
tone as measured by RSA. Literature findings on this
issue are divergent, with a number of studies report-
ing significantly reduced RSA [11-14], and others find-
ing no atypicalities [47,62]. This discrepancy may be
related tomethodological differences, age-related changes
(for example, developmental trend), and other confound-
ing variables (anxiety, attention, level of intervention
received). For example, our study was different than
[11,12,14] in the baseline task used (such as movie watch-
ing versus sitting quietly), suggesting that task conditions
may play a role in measurement of baseline ANS arousal.
Future well-controlled studies are needed to further inves-
tigate these issues.
Differences in task reactivity
Our data showed a blunted HR response to the social anx-
iety task in the ASD group. This pattern has been reported
consistently in three studies examining ANS reactivity to
psychosocial challenges [15-17], and was previously sug-
gested to be a manifestation of response saturation due
to basal hyperarousal. Consistent with this hypothesis,
we found a significant negative association between HR
change and scores on the generalized anxiety subscale
of the RCADS. This atypical response, however, has not
been previously reported in ANS studies of public speak-
ing involving social phobics, and may therefore be unique
to ASD. Interestingly, the blunted response was not seen
in our second anxiety task (Stroop Color-Interference
task). Given that impairments in social interaction are a
defining feature of ASD, we hypothesize that the atypi-
cal response found in this study may reflect differences
in subjective experiences of the task (such as motivation,
attention, or judgement of the social threat). This hypoth-
esis is consistent with our finding of a positive correla-
tion between HR change, and IQ and task performance
[63,72].
Our data also revealed increased RSA reactivity to the
Reading the Mind in the Eyes task in the ASD group.
This task is a test of theory of mind (ToM) or the abil-
ity to recognize others’ emotions and states of mind. A
domain affected in ASD, ToM allows for fostering of
appropriate social behaviors, establishment of reciprocal
relationships, and development of social competence [12].
Social function, and ToM in particular, have also been
linked to RSA regulation, as the “vagal brake” promotes
calm behavioral states that are needed for social function,
with greater ability to reduce RSA associated with bet-
ter outcomes [21]. While we did not find an association
between severity of social communication symptomatol-
ogy as measured by the SCQ, our data did show that IQ
was a significant predictor of RSA change in the ASD
group. In the absence of performance differences between
the groups, large RSA variability may reflect higher degree
of effort or compensatory mechanisms applied by the
ASD group. The latter is consistent with atypical central
nervous system responses to the Eyes task (for example,
decreased amygdala activation) [73].
Limitations
Our data suggest basal hyperarousal in the ASD group.
However, our baseline condition (movie watching) may
not reflect a true “rest” state, and the pattern of hyper-
arousal at baseline may reflect increased ANS lability to
laboratory conditions. Considering that we did not find
HR over-reactivity to our experimental tasks, this scenario
is unlikely.
Our sample size may have limited our ability to detect
significant group differences in reactivity to attention and
response inhibition tasks. Moreover, this sample hindered
the analysis of subgroups that may exhibit different phys-
iological responses (hyperarousal versus hypoarousal).
Additionally, while our typically developing group was
screened based on medical history, we were unable to
report on the presence of any undiagnosed ASD traits in
this population (for example, by using the SCQ).
Finally, the ANS has complex and bidirectional interac-
tions with the central nervous system and the endocrine
system. As such, our measures of cardiac autonomic
control reflect the final common pathway of these
interactions.
Conclusions
Recently, it has been suggested that ASD may be asso-
ciated with autonomic dysregulation. Our data are con-
sistent with this hypothesis. In particular, we found basal
heart rate hyperarousal and aytpical heart rate and res-
piratory sinus arrhythmia reactivity to two social tasks
(public speaking and Reading the Mind in the Eyes).
Future studies are needed to examine the central nervous
system correlates of this dysregulation, as well as its asso-
ciation with co-morbid anxiety and ASD symptomatology.
The finding of ANS dysregulation may ultimately suggest
new treatment targets in ASD, and lead to inexpensive
and non-invasive markers for deficits associated with this
disorder.
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